Entourage Health Corp. reaffirmed preliminary unaudited revenue guidance for the fiscal year ended December 31, 2021. For the year, the company expects total revenues to be $54.8 million, an increase of 54% year-over-year, representing a record year of sales growth and expanded market share across its adult-use and medical sales channels.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | +50.00% | +50.00% | 0.00% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.25M | |
+36.12% | 3.97B | |
+121.17% | 2.03B | |
+134.92% | 76.66M |
- Stock Market
- Equities
- ENTG Stock
- News Entourage Health Corp.
- Entourage Health Corp. Reaffirms Preliminary Unaudited Revenue Guidance for the Fiscal Year Ended December 31, 2021